Home/Pipeline/CYWC628

CYWC628

Wound Healing

DiscoveryActive

Key Facts

Indication

Wound Healing

Phase

Discovery

Status

Active

Company

FibroBiologics

About FibroBiologics

FibroBiologics is a clinical-stage biotech focused on developing fibroblast cell-based therapies for chronic diseases, positioning fibroblasts as a superior alternative to mesenchymal stem cells. The company has established a robust intellectual property portfolio of over 270 patents and has achieved an FDA IND clearance for its lead program in Degenerative Disc Disease. Its strategy hinges on demonstrating clinical proof-of-concept for its fibroblast platform across multiple high-need indications to validate its core technological thesis and unlock significant value.

View full company profile

Therapeutic Areas

Degenerative Disc Disease Multiple Sclerosis Wound Healing Oncology Autoimmune Anti-Aging

Other Wound Healing Drugs

Drug	Company	Phase	Status
BXT-25	BioXyTran	Preclinical	Active
Advanced Wound Care Program	Ionic Pharmaceuticals	Research	Active
Wound Care Formulations	MediCell Technologies	Commercial	Active
SBX 1977	Stramsen Biotech	Early-stage Clinical	Active
StroMel™ (Planned)	Akan Biosciences	Planned	Active
MRG-001	MedRegen	Phase 2	Active (Study Completed, Data Pending)
CordLining Stem Cell Therapy	CellResearchCorp	Phase 1	Active
ABCcolla® Collagen Matrix	ACRO Biomedical	Commercial	Active